Raw Glatiramer Acetate powder (147245-92-9) video
Raw Glatiramer Acetate powder (147245-92-9) Description
Glatiramer Acetate powder (147245-92-9) is a synthetic protein that simulates myelin basic protein, a component of the myelin that insulates nerve fibers in the brain and spinal cord. This drug seems to block myelin-damaging T-cells through a mechanism that is not completely understood.
Raw Glatiramer Acetate powder (147245-92-9) injection is approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with relapsing forms of multiple sclerosis.
Raw Glatiramer Acetate powder (147245-92-9) Specifications
|Product Name||Glatiramer acetate|
|Chemical Name||(S)-2,6-diaminohexanoic acid compound with(S)-2-amino-3-(4-hydroxyphenyl)propanoic acid and (S)-2-aminopentanedioic acid and (S)-2-aminopropanoic acid and acetic acid (1:1:1:1:1)|
|Brand Name||Copaxone (Teva).|
|Solubility||<6.24mg/mL in DMSO|
|Application||GA treatment led to sustained augmentation of the expression of BDNF, NT-3, and NT-4 in various brain regions.|
PRECAUTION AND DISCLAIMER:
This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.